Lot 949 The Nixon Release

  • TypeLand
  • Frontage12.5m
  • Lot no949
  • Land size420m2
Boosting the Boost Campaign

The end of the financial year is just weeks away and with it comes the end of the First Home Buyer’s Boost. But Stockland is offering one final “boost” of its own with an additional $5000* off selected lots in Queensland.

Download the terms and conditions here.*


The Nixon Release is beautifully positioned between 2 new park opening in 2018 and the future 10 hectare recreation park. The release includes 13 home sites in a quiet, secluded enclave of the community. Designs require your garage to be located at the back, providing picturesque views of the park.

  • A quiet, secluded enclave of the community
  • All lots in the release adjoin two exciting new parks opening in 2018
  • Bike and walking paths connect you to the school, cafes and future shopping centre
  • Rear-loaded designs required, perfect for your bespoke dream home
Show more
*Price is correct as at date of publication and is subject to change without notice or obligation. Applies to selected House & Land Package only. Subject to availability. Stockland is only responsible for the sale of the land. Price is based on the Builder’s standard plans and specifications, standard inclusions and preferred building surveyor. Price does not include stamp duty, registration fees, additional costs that may be incurred under the Building Contract (eg due to delays in titling the lot) or any other incidental fees associated with the acquisition of land or a home or the construction of a home.
Price correct as at 18/04/2018. See full Terms & Conditions for details.

Explore Aura

Use the map to see and interact with the features of Aura

The contents of this map are for illustrative purposes only and are subject to change without prior notice.


Over 200km of future bikeways & walking paths

90ha Future City Centre & village shopping centres

Future People's Place, a South Bank-style parkland

Over 700ha of conservation and park areas


Aura proves to be the right medicine for new buyers